BILCARE LTD. Valuation
BI · Healthcare · Current price ₹91.2
Is BILCARE LTD. undervalued?
DocStoX estimates the fair value of BILCARE LTD. at ₹52 per share, versus the current market price of ₹91. That puts the stock about -42.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹73), Relative P/E (₹19), Graham floor (₹37). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹19 (bear) to ₹52 (base) to ₹73 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
BILCARE LTD. trades at a P/E of 124.9x and a P/B of 0.7x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on BILCARE LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.